Insights & News

Insights & News

We are glad to present you with an overview of the Russian regulations in the sphere of pharmaceuticals and life sciences for the 1st half of 2023. ...
17 July 2023 Newsletters
We are glad to present you a current digest of the most significant bills, regulatory changes, and measures affecting the pharmaceutical and healthcare industry for the period from June to October...
01 November 2022 Newsletters
We would like to inform you that the Russian President has signed amendments to Article 1360 the Civil Code of the Russian Federation ('Russian Civil Code'), in terms of providing compulsory licenses...
20 May 2021 Newsletters
We would like to inform you about several important news items, in the pharmaceutical industry, at the beginning of 2021. ...
11 February 2021 Newsletters
On September 18th, 2020, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) adopted a new [Order](https://cdnimg.rg.ru/pril/195/05/28/59666.pdf 'Order') approving the criteria for...
02 October 2020 Newsletters
As of July 1, the Russian requirements on digital labelling of medications and transmitting the data on medications’ turnover to the Chestny ZNAK system have become mandatory. ...
14 July 2020 Newsletters
We would like to share our views on the latest trend in the criminal enforcement of the cartel crimes in the pharma and medical equipment markets. ...
12 February 2020 Newsletters
During 2017-2018, the Federal Antimonopoly Service of Russia (“FAS”) paid close attention to advertisements of OTC medicines and considered large number cases of violations of advertising legislation...
14 January 2019 Newsletters
We use cookies to offer better performance of the website and fulfill some other purposes specified in the Privacy Policy. By way of ticking the box you provide your consent to use of cookies. Otherwise, we will only use technical cookies, which are necessary for proper functioning of the website.
Accept